Desoxyn and Radiculopathy - a phase IV clinical study of FDA data

Summary:

Radiculopathy is reported as a side effect among people who take Desoxyn (methamphetamine hydrochloride), especially for people who are female, 30-39 old, also take Celexa, and have Sleep apnea syndrome.

The phase IV clinical study analyzes which people have Radiculopathy when taking Desoxyn. It is created by eHealthMe based on reports of 849 people who have side effects when taking Desoxyn from the FDA, and is updated regularly.

What is Desoxyn?

Desoxyn has active ingredients of methamphetamine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 903 Desoxyn users. Check the latest studies of Desoxyn.

What is Radiculopathy?

Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly) is found to be associated with 742 drugs and 604 conditions by eHealthMe. Check the latest studies of Radiculopathy.

On Apr, 11, 2026

849 people reported to have side effects when taking Desoxyn.
Among them, 23 people (2.71%) have Radiculopathy.

Among these 23 people:

What is the gender of people who have Radiculopathy when taking Desoxyn? *

female: 100 %
male: 0.0 %

What is the age of people who have Radiculopathy when taking Desoxyn? *

What are other drugs people take besides Desoxyn? *

What are other side effects people have besides Radiculopathy? *

Weight Increased: 23 people, 100.00%
Neuropathy Peripheral (surface nerve damage): 23 people, 100.00%
Muscle Spasms (muscle contraction): 23 people, 100.00%
Mesenteric Vascular Insufficiency (insufficient vascular supply to mesenteric): 23 people, 100.00%
Memory Loss: 23 people, 100.00%
Malaise (a feeling of general discomfort or uneasiness): 23 people, 100.00%
Intervertebral Disc Disorder (spinal disc disorder): 23 people, 100.00%
Injury: 23 people, 100.00%
Infection: 23 people, 100.00%
Implant Site Infection: 23 people, 100.00%

What are the existing conditions these people have? *

Sleep Apnea Syndrome: 23 people, 100.00%
Bone Density Decreased: 13 people, 56.52%
Metastases To Bone (cancer spreads to bone): 6 people, 26.09%
Bone Loss: 4 people, 17.39%
Pain: 1 person, 4.35%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Desoxyn and have Radiculopathy?

- Check whether Radiculopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Desoxyn:

Desoxyn (903 reports)

Radiculopathy treatments and more:

Radiculopathy (5,655 reports)

Browse all side effects of Desoxyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Radiculopathy:

Radiculopathy (742 drugs)

Browse all the conditions that are associated with Radiculopathy:

Radiculopathy (604 conditions)

Related publications that referenced our studies

Foroughipour M, Farzadfard MT, Aghaee M, Ghabeli-Juibary A, Rezaietalab F, "Methamphetamine Related Radiculopathy: Case Series and Review of Literature", Asia Pacific Journal of Medical Toxicology, 2013 Jun .
Foroughipour M, Farzadfard MT, Aghaee M, Ghabeli-Juibary A, Rezaietalab F, "Methamphetamine Related Radiculopathy: Case Series and Review of Literature", Asia Pacific Journal of Medical Toxicology, 2013 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on methamphetamine hydrochloride (the active ingredients of Desoxyn) and Desoxyn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.